Evidence-Based GI
Subcutaneous Infliximab for Maintenance of IBD Remission: Added Convenience With Potential for Improved Efficacy? Elie S. Al Kazzi, MD, MPH…
On-Demand Vonoprazan for Non-Erosive Reflux Disease Symptoms: A New Option Christopher Vélez, MD Associate Program Director, Advanced Fellowship in…
Suboptimal Adherence to Guidelines When Recommending Timing of Repeat Colonoscopy Margaret J Zhou, MD, MS Clinical Assistant Professor of Medicine,…
Reintroducing Foods After Completing Restrictive Low FODMAP Diet Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief (Emeritus), Gastroenterology Section, John D.…
Quality Indicators for Colonoscopy: New Targets… But Will They Be Measured? Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief (Emeritus), Gastroenterology…
Decreasing Cirrhosis Risk in MASLD: Don’t Drink Alcohol! Nicole E. Rich, MD, MSCS Assistant Professor, Associate Director of the Liver…
A PPI a Day Keeps the GI Bleed Away in the ICU Philip N. Okafor, MD, MPH Senior Associate Consultant,…
A Laser Ruler To Hit The Mark On Polyp Size Timothy Yen, MD Assistant Professor of Medicine, Division of Gastroenterology,…
ACG Guideline on Treatment of Helicobacter pylori: New Recommendations… Will Practice Change? Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief (Emeritus),…
Risankizumab Is Superior to Placebo for Induction and Maintenance of Moderate-Severe Ulcerative Colitis (UC): Assessing the UC Treatment Paradigm Rahul…